Evaluation of the efficacy of treatment with mucosal bacterial vaccines(autovaccines) versus suppressive antibiotic treatment in subjects with hip or knee prosthesis infections.

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-520226-10-00

Acronym

VACAB-2022

Enrollment

Registered

2025-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with hip or knee infections

Brief summary

Clinical course: Presence of exudate, redness of the wound, pain, or other clinical signs of infection.

Detailed description

Safety assessment: local and systemic adverse events

Interventions

DRUGFLUCONAZOLE

DRUGSULFAMETHOXAZOLE AND TRIMETHOPRIM

DRUGAMOXICILLIN

DRUGMETRONIDAZOLE

DRUGCIPROFLOXACIN

DRUGAMOXICILLIN AND BETA-LACTAMASE INHIBITOR

DRUGCLINDAMYCIN

DRUGDOXYCYCLINE

DRUGLINEZOLID

DRUGSODIUM CHLORIDE SOLUTION 0.9%

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Clinical course: Presence of exudate, redness of the wound, pain, or other clinical signs of infection.	—

Secondary

Measure	Time frame
Safety assessment: local and systemic adverse events	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026